Regulatory T cells in experimental allergic encephalomyelitis. II. T cells functionally antagonistic to encephalitogenic MBP‐specific T cells show persistent expression of FasL

Naive LEW rats and animals that have recovered from active or adoptive EAE contain a subset of T cells that inhibit EAE in secondary recipients and are lytic for MBP‐reactive T cell lines in culture. Here we explore various features of these regulatory T cell populations (RTC) with respect to (1) their frequency in animals following immunization with syngeneic MBP‐reactive cell lines, (2) their ability to inhibit proliferative responses by MBP‐reactive cell lines in culture, (3) their ability to lyse MBP‐specific target cells, and especially (4) their prolonged expression of high levels of FasL following activation in culture correlating with their lytic effects on A20, a FasL‐sensitive mouse lymphoma cell line. Inhibition studies indicate that mAbs specific for MHC class I and MHC class II molecules inhibit lysis of syngeneic MBP‐reactive target T cells, soluble Fas protein shows some inhibition, but none of these agents inhibits the lytic effects of activated RTC on the A20 cell line. J. Neurosci. Res. 58:357–366, 1999. © 1999 Wiley‐Liss, Inc.

[1]  D. Wilson,et al.  Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease. , 1999, International immunology.

[2]  J. Mountz,et al.  Cell death mediated by Fas‐FasL interaction between glial cells and MBP‐reactive T cells , 1998 .

[3]  S. Nagata,et al.  Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.

[4]  C. Janeway,et al.  The Role of Fas in Autoimmune Diabetes , 1997, Cell.

[5]  M. Iwata,et al.  Increased Fas antigen on T cells in multiple sclerosis , 1996, Journal of Neuroimmunology.

[6]  E. Robinet,et al.  Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. , 1996, Journal of immunology.

[7]  J. Menonna,et al.  Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain , 1996, The Journal of experimental medicine.

[8]  R. Vabulas,et al.  Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation‐associated apoptosis , 1996, European journal of immunology.

[9]  D. Green,et al.  CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. , 1996, Immunity.

[10]  G. Mills,et al.  Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. , 1996, Cellular immunology.

[11]  A. Abbas,et al.  Die and Let Live: Eliminating Dangerous Lymphocytes , 1996, Cell.

[12]  F. Ramsdell,et al.  Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.

[13]  D. Vaux Ways around rejection , 1995, Nature.

[14]  H. Luthra,et al.  Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. , 1995, Journal of immunology.

[15]  J. Tschopp,et al.  Down‐modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fasligand interaction , 1995, European journal of immunology.

[16]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[17]  H. Maecker,et al.  In situ detection and characterization of apoptotic thymocytes in human thymus. Expression of bcl-2 in vivo does not prevent apoptosis. , 1995, Journal of immunology.

[18]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[19]  Masato Tanaka,et al.  Expression of the functional soluble form of human fas ligand in activated lymphocytes. , 1995, The EMBO journal.

[20]  J. Sprent,et al.  T-cell apoptosis detected in situ during positive and negative selection in the thymus , 1994, Nature.

[21]  P. Erb,et al.  Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. , 1994, Journal of immunology.

[22]  P. Bossù,et al.  Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. , 1993, Journal of immunology.

[23]  F. Ramsdell,et al.  Fas transduces activation signals in normal human T lymphocytes , 1993, The Journal of experimental medicine.

[24]  J. Bluestone,et al.  Evidence for programmed cell death of self‐reactive γδ T cell receptor‐positive thymocytes , 1993 .

[25]  T. Pohl,et al.  Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. , 1993, Immunology today.

[26]  E. Reinherz,et al.  Thymic and peripheral apoptosis of antigen‐specific T cells might cooperate in establishing self tolerance , 1993, European journal of immunology.

[27]  N. Letvin,et al.  Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. , 1992, The Journal of clinical investigation.

[28]  N. Copeland,et al.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.

[29]  G. Panayi,et al.  Limiting dilution analysis of proliferative T cell responses to mycobacterial 65‐kDa heat‐shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis , 1991, European journal of immunology.

[30]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[31]  Y. Matsumoto,et al.  Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis. , 1990, Immunology.

[32]  W. Klinkert,et al.  Functional heterogeneity among CD4+ encephalitogenic T cells in recruitment of CD8+ T cells in experimental autoimmune encephalomyelitis. , 1989, Journal of immunology.

[33]  A. Ben-nun,et al.  Regulatory circuits in autoimmunity: recruitment of counter‐regulatory CD8+ T cells by encephalitogenic CD4+ T line cells , 1988, European journal of immunology.

[34]  H. Wekerle,et al.  Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions , 1988, Nature.

[35]  I. Cohen,et al.  Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific. , 1983, Journal of immunology.

[36]  M. Dallman,et al.  Functions of Rat T‐Lymphocyte Subsets Isolated by Means of Monoclonal Antibodies , 1983, Immunological reviews.

[37]  I. Cohen,et al.  T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells , 1983, European journal of immunology.

[38]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.

[39]  D. Hinrichs,et al.  Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. , 1981, Journal of immunology.

[40]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line , 1981, European journal of immunology.

[41]  D. Willenborg Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. , 1979, Journal of immunology.

[42]  R. Swanborg Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. , 1975, Journal of immunology.

[43]  R. Swanborg,et al.  Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats. , 1974, Journal of immunology.